Genetics of Bone Mineral Density in Two Populations

两个人群骨矿物质密度的遗传学

基本信息

项目摘要

DESCRIPTION (provided by applicant): Osteoporotic fractures and low bone mineral density (BMD) are serious public health burdens. Substantial evidence exists that BMD is partially determined by genetics, although to date, few genes influencing variation in BMD have been identified. The majority of genetic studies have been conducted in Caucasian populations; examining the relationship between genetics and BMD in an ethnically diverse population (Mexican Americans) and a founder population (Amish) may facilitate identification of novel genetic loci associated with BMD. Our strategy is to: 1) conduct a genome wide association study (GWAS) in two populations of large, multigenerational families; 2) carry out formal meta-analysis of BMD between the two populations; and 3) conduct pathway based analyses and tests of gene-by-gene interaction among genes within these biological pathways. These research objectives were developed to complement the training component of this proposal, the objectives of which are to: 1) obtain more advance training in the genetics of BMD; 2) develop expertise with contemporary methods of genetic analysis employed in GWAS; and 3) gain experience with family-based genetic epidemiology studies. The goal of this study is to identify genes that influence BMD, which may provide new insights into the underlying biology and risk factors of bone disease.
描述(由申请人提供):骨质疏松性骨折和低骨矿物质密度(BMD)是严重的公共卫生负担。大量证据表明,BMD部分由遗传学决定,尽管迄今为止,很少有基因影响BMD的变化已被确定。大多数遗传学研究都是在高加索人群中进行的;在种族多样的人群(墨西哥裔美国人)和创始人人群(阿米什人)中检查遗传学和BMD之间的关系可能有助于识别与BMD相关的新遗传基因座。我们的战略是:1)在两个多代大家庭的群体中进行全基因组关联研究(GWAS); 2)在两个群体之间进行正式的BMD荟萃分析; 3)进行基于途径的分析和这些生物学途径内基因间基因间相互作用的测试。制定这些研究目标是为了补充本提案的培训部分,其目标是:1)获得BMD遗传学方面的更高级培训; 2)发展GWAS中采用的当代遗传分析方法的专业知识; 3)获得以家庭为基础的遗传流行病学研究的经验。本研究的目的是确定影响BMD的基因,这可能为骨骼疾病的潜在生物学和危险因素提供新的见解。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Laura Maria Yerges-Armstrong其他文献

Laura Maria Yerges-Armstrong的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Laura Maria Yerges-Armstrong', 18)}}的其他基金

The contribution of exonic variants to cardiovascular disease risk in the Amish
外显子变异对阿米什人心血管疾病风险的贡献
  • 批准号:
    8703773
  • 财政年份:
    2013
  • 资助金额:
    $ 5.05万
  • 项目类别:
The contribution of exonic variants to cardiovascular disease risk in the Amish
外显子变异对阿米什人心血管疾病风险的贡献
  • 批准号:
    8581417
  • 财政年份:
    2013
  • 资助金额:
    $ 5.05万
  • 项目类别:
Genetics of Bone Mineral Density in Two Populations
两个人群骨矿物质密度的遗传学
  • 批准号:
    7911123
  • 财政年份:
    2010
  • 资助金额:
    $ 5.05万
  • 项目类别:

相似国自然基金

Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
  • 批准号:
    31171277
  • 批准年份:
    2011
  • 资助金额:
    60.0 万元
  • 项目类别:
    面上项目
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
  • 批准号:
    31070748
  • 批准年份:
    2010
  • 资助金额:
    34.0 万元
  • 项目类别:
    面上项目

相似海外基金

Sex as a biological variable in the development of inflammatory arthritis
性别作为炎症性关节炎发展的生物学变量
  • 批准号:
    473402
  • 财政年份:
    2022
  • 资助金额:
    $ 5.05万
  • 项目类别:
    Operating Grants
Development of low-load exercise therapy using molecular biological techniques for rheumatoid arthritis with sarcopenia
利用分子生物学技术开发低负荷运动疗法治疗类风湿性关节炎伴肌肉减少症
  • 批准号:
    21K11292
  • 财政年份:
    2021
  • 资助金额:
    $ 5.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Anti-nuclear antibody development during biological disease-modifying anti rheumatic drugs in patients with rheumatoid arthritis
类风湿性关节炎患者使用生物疾病缓解抗风湿药物期间抗核抗体的形成
  • 批准号:
    19K08915
  • 财政年份:
    2019
  • 资助金额:
    $ 5.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Relationship between HLA-DRB1 and therapeutic response to biological disease-modifying antirheumatic drugs in rheumatoid arthritis
HLA-DRB1 与类风湿关节炎生物疾病缓解抗风湿药物治疗反应的关系
  • 批准号:
    18K16139
  • 财政年份:
    2018
  • 资助金额:
    $ 5.05万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
MICA: BIOlogical Factors that Limit sustAined Remission in rhEumatoid arthritis (the BIO-FLARE study)
MICA:限制类风湿性关节炎持续缓解的生物因素(BIO-FLARE 研究)
  • 批准号:
    MR/N026977/1
  • 财政年份:
    2017
  • 资助金额:
    $ 5.05万
  • 项目类别:
    Research Grant
The Effects of Psoriatic Arthritis on Coronary Flow Reserve and Markers of Inflammation and Evaluation of the Response to Biological Therapy
银屑病关节炎对冠状动脉血流储备和炎症标志物的影响以及生物治疗反应的评估
  • 批准号:
    310303
  • 财政年份:
    2014
  • 资助金额:
    $ 5.05万
  • 项目类别:
    Operating Grants
Inhibitory effects of combination therapy of denosumab, anti-RANKL antibody, and biological DMARD on bone and cartilage destruction in patients with rheumatoid arthritis
地诺塞麦、抗RANKL抗体和生物DMARD联合治疗对类风湿性关节炎患者骨和软骨破坏的抑制作用
  • 批准号:
    26462290
  • 财政年份:
    2014
  • 资助金额:
    $ 5.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of heparin-based nanoparticles with multi-functional biological properties intended for rheumatoid arthritis therapy
开发具有多功能生物学特性的肝素纳米颗粒,用于类风湿性关节炎治疗
  • 批准号:
    23659022
  • 财政年份:
    2011
  • 资助金额:
    $ 5.05万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Establishment of individualized dosage regimen based on pharmacodynamic model considering efficacy expression process of biological agents for rheumatoid arthritis
考虑类风湿关节炎生物制剂药效表达过程的药效模型个体化给药方案的建立
  • 批准号:
    21590181
  • 财政年份:
    2009
  • 资助金额:
    $ 5.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A epidemiological study of long-term safety of biological disease-modifying antirheumatic drugs for patients with rheumatoid arthritis and risk factors for adverse drug reactions.
生物缓解病情抗风湿药物治疗类风湿关节炎患者的长期安全性及药物不良反应危险因素的流行病学研究。
  • 批准号:
    20390158
  • 财政年份:
    2008
  • 资助金额:
    $ 5.05万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了